Kamil Ali-Jackson
Insider Reports History
- Location
- Malvern, PA
- Signature
- /s/ Spencer Brown, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Kamil Ali-Jackson:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | Director | Common Stock | 9,375 | $178,687 | $19.06 | 23 May 2025 | Direct |
| Aclaris Therapeutics, Inc. | Chief Legal Officer | Common Stock | 160,214 | $168,225 | $1.05 | 03 Jan 2022 | Direct |
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 54,876 | 12 Jan 2026 | Direct | ||
| RIGEL PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 3,000 | 23 May 2025 | Direct | ||
| Aclaris Therapeutics, Inc. | Chief Legal Officer | Restricted Stock Units | 0 | $1.05 | 03 Jan 2022 | Direct |
Insider Reports Filed by Kamil Ali-Jackson
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PDSB | PDS Biotechnology Corp | 12 Jan 2026 | 1 | $0 | 4 | Director | 03 Mar 2026, 18:47 |
| PDSB | PDS Biotechnology Corp | 11 Jun 2025 | 1 | $0 | 4 | Director | 11 Jun 2025, 18:00 |
| RIGL | RIGEL PHARMACEUTICALS INC | 23 May 2025 | 2 | $0 | 4 | Director | 28 May 2025, 17:27 |
| PDSB | PDS Biotechnology Corp | 24 Jun 2024 | 1 | $0 | 4 | Director | 25 Jun 2024, 16:05 |
| RIGL | RIGEL PHARMACEUTICALS INC | 25 May 2024 | 2 | $0 | 4 | Director | 29 May 2024, 19:19 |
| PDSB | PDS Biotechnology Corp | 14 Jul 2023 | 1 | $0 | 4 | Director | 17 Jul 2023, 17:28 |
| RIGL | RIGEL PHARMACEUTICALS INC | 26 May 2023 | 2 | $0 | 4 | Director | 12 Jul 2023, 18:45 |
| PDSB | PDS Biotechnology Corp | 28 Jun 2022 | 1 | $0 | 4 | Director | 29 Jun 2022, 16:15 |
| RIGL | RIGEL PHARMACEUTICALS INC | 20 May 2022 | 2 | $0 | 4 | Director | 23 May 2022, 17:50 |
| ACRS | Aclaris Therapeutics, Inc. | 03 Jan 2022 | 8 | $0 | 4 | Chief Legal Officer | 05 Jan 2022, 15:33 |
| RIGL | RIGEL PHARMACEUTICALS INC | 16 Dec 2021 | 1 | $0 | 4 | Director | 17 Dec 2021, 15:22 |
| RIGL | RIGEL PHARMACEUTICALS INC | 16 Dec 2021 | 0 | $0 | 3 | Director | 17 Dec 2021, 15:20 |
| PDSB | PDS Biotechnology Corp | 15 Jun 2021 | 2 | +$99,994 | 4 | Director | 17 Jun 2021, 19:09 |
| ACRS | Aclaris Therapeutics, Inc. | 03 Jun 2021 | 1 | -$208,421 | 4 | Chief Legal Officer | 04 Jun 2021, 19:52 |
| ACRS | Aclaris Therapeutics, Inc. | 01 Jun 2021 | 8 | -$996,963 | 4 | Chief Legal Officer | 02 Jun 2021, 21:47 |
| ACRS | Aclaris Therapeutics, Inc. | 06 May 2021 | 8 | -$261,210 | 4 | Chief Legal Officer | 07 May 2021, 18:28 |
| ACRS | Aclaris Therapeutics, Inc. | 11 Mar 2021 | 1 | $0 | 4 | Chief Legal Officer | 22 Nov 2021, 15:03 |